Torrent Pharmaceuticals Ltd
NSE :TORNTPHARM BSE :500420 Sector : PharmaceuticalsBuy, Sell or Hold TORNTPHARM? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
04 Oct 3473.55 (2.40%) | 03 Oct 3392.15 (0.66%) | 01 Oct 3369.90 (-0.78%) | 30 Sep 3396.55 (-2.47%) | 27 Sep 3482.60 (2.06%) | 26 Sep 3412.30 (-0.46%) | 25 Sep 3428.05 (-1.23%) | 24 Sep 3470.90 (0.38%) | 23 Sep 3457.65 (-0.00%) | 20 Sep 3457.80 (3.16%) | 19 Sep 3351.90 (-0.23%) | 18 Sep 3359.60 (-2.71%) | 17 Sep 3453.25 (-0.02%) | 16 Sep 3453.90 (0.06%) | 13 Sep 3451.70 (-0.28%) | 12 Sep 3461.45 (0.75%) | 11 Sep 3435.55 (0.27%) | 10 Sep 3426.15 (-0.14%) | 09 Sep 3431.10 (0.42%) | 06 Sep 3416.70 (-0.75%) | 05 Sep 3442.50 (-0.59%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Neutral
Medium Term Investors
Very Bullish
Long Term Investors
Very Bullish
Moving Averages
5 DMA
Bullish
3423.21
10 DMA
Bullish
3434.97
20 DMA
Bullish
3429.35
50 DMA
Bullish
3363.12
100 DMA
Bullish
3093.29
200 DMA
Bullish
2813.85
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On Oct 04, 2024 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 3667.05 | 3580.95 | 3512 | - | - |
R2 | 3580.95 | 3527.55 | 3499.18 | 3589.05 | - |
R1 | 3527.25 | 3494.55 | 3486.37 | 3543.45 | 3554.1 |
P | 3441.15 | 3441.15 | 3441.15 | 3449.25 | 3454.58 |
S1 | 3387.45 | 3387.75 | 3460.74 | 3403.65 | 3414.3 |
S2 | 3301.35 | 3354.75 | 3447.92 | 3309.45 | - |
S3 | 3247.65 | 3301.35 | 3435.11 | - | - |
Key Metrics
EPS
44.41
P/E
78.26
P/B
17.22
Dividend Yield
0.81%
Market Cap
1,17,555 Cr.
Face Value
5
Book Value
201.78
ROE
25.38%
EBITDA Growth
927 Cr.
Debt/Equity
0.72
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Torrent Pharmaceuticals Ltd Quaterly Results
Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | |
INCOME | 2625 | 2686 | 2787 | 2776 | 2883 |
PROFIT | 378 | 386 | 381.22 | 449 | 457 |
EPS | 11.18 | 11.39 | 13.1 | 13.27 | 13.51 |
Torrent Pharmaceuticals Ltd Quaterly Results
Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | |
INCOME | 2132 | 2161 | 2112 | 2219 | 2459 |
PROFIT | 323 | 327 | 297 | 410 | 469 |
EPS | 9.55 | 9.65 | 8.78 | 12.12 | 13.86 |
Profit & Loss (Figures in Rs. Crores)
Torrent Pharmaceuticals Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 4999.87 | 7060.27 | 6178.72 | 6610.87 | 7646.41 | 8193.74 | 8340.72 | 8630.74 | 9499.1 | 11029.14 | |
PROFIT | 739.53 | 1834.37 | 879.74 | 636.59 | 595.93 | 1001.92 | 1239.71 | 1076.48 | 1217.5 | 1581.49 | |
EPS | 21.06 | 51.21 | 27.58 | 20.04 | 12.89 | 30.28 | 36.99 | 22.96 | 36.79 | 48.94 |
Torrent Pharmaceuticals Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 3866.79 | 5782.98 | 4862 | 4809.09 | 6149.41 | 6462.2 | 6719.05 | 6964.83 | 7648.64 | 8692.87 | |
PROFIT | 612.66 | 1703.84 | 797.6 | 440.67 | 714.33 | 914.33 | 1125.1 | 984.59 | 1023.42 | 1342.2 | |
EPS | 17.29 | 47.3 | 25.24 | 14.24 | 22.03 | 27.73 | 33.62 | 29.29 | 31.06 | 40.1 |
Balance Sheet (Figures in Rs. Crores)
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 169.23 | 169.23 | 84.62 | 84.62 | 84.62 | 84.62 | 84.62 | 84.62 | 84.62 | 84.62 |
Reserves Total | 6,686.92 | 6,028.84 | 5,868.33 | 5,752.55 | 4,738.6 | 4,639.73 | 4,537.57 | 4,265.51 | 3,409.48 | 2,405.94 |
Total Shareholders Funds | 6,856.15 | 6,198.07 | 5,952.95 | 5,837.17 | 4,823.22 | 4,724.35 | 4,622.19 | 4,350.13 | 3,494.1 | 2,490.56 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0.52 | 0.49 | 0.46 | 0.43 |
Secured Loans | 3,149.71 | 4,530 | 3,295.03 | 4,331.79 | 5,179.69 | 5,548.24 | 5,663.03 | 2,496.38 | 2,338.45 | 2,719.12 |
Unsecured Loans | 872.23 | 838.56 | 774.62 | 542.34 | 604.66 | 489.86 | 799.29 | 13.75 | 13.23 | 21.23 |
Total Debt | 4,021.94 | 5,368.56 | 4,069.65 | 4,874.13 | 5,784.35 | 6,038.1 | 6,462.32 | 2,510.13 | 2,351.68 | 2,740.35 |
Other Liabilities | 454.89 | 415.39 | 378.2 | 382.59 | 457.14 | 310.83 | 306.84 | 270.97 | 256.01 | 215 |
Total Liabilities | 11,332.98 | 11,982.02 | 10,400.8 | 11,093.89 | 11,064.71 | 11,073.28 | 11,391.87 | 7,131.72 | 6,102.25 | 5,446.34 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 13,484.57 | 12,811.62 | 10,728.19 | 10,511.53 | 10,334.13 | 9,935.43 | 9,449.48 | 4,909.8 | 3,793.53 | 3,542.93 |
Less: Accumulated Depreciation | 5,346.46 | 4,690.17 | 4,305.54 | 3,446.9 | 2,801.01 | 2,187.72 | 1,594.8 | 1,221.36 | 934.45 | 710.27 |
Net Block | 8,138.11 | 8,121.45 | 6,422.65 | 7,064.63 | 7,533.12 | 7,747.71 | 7,854.68 | 3,688.44 | 2,859.08 | 2,832.66 |
Capital Work in Progress | 360.51 | 765.4 | 629.82 | 889.38 | 711.93 | 617.12 | 646.94 | 519.49 | 1,041.58 | 678.33 |
Investments | 172.84 | 198.79 | 226.31 | 181.14 | 2.11 | 353.44 | 492.36 | 803.64 | 779.68 | 297.65 |
Inventories | 2,279.07 | 2,229.64 | 2,462.32 | 2,681.2 | 2,148.22 | 1,935.15 | 1,966.3 | 1,559.15 | 1,357.98 | 1,067.17 |
Sundry Debtors | 1,844.3 | 1,943.82 | 1,632.48 | 1,523.37 | 1,649.34 | 1,435.71 | 1,253.45 | 950.89 | 1,445.09 | 1,587.26 |
Cash and Bank Balance | 839.04 | 571.46 | 403.41 | 603.5 | 666.65 | 816.04 | 867.23 | 893.72 | 647.03 | 567.36 |
Loans and Advances | 508.03 | 412.71 | 482.8 | 574.38 | 514.83 | 499.29 | 683.16 | 672.16 | 459.34 | 532.03 |
Total Current Assets | 5,470.44 | 5,157.63 | 4,981.01 | 5,382.45 | 4,979.04 | 4,686.19 | 4,770.14 | 4,075.92 | 3,909.44 | 3,753.82 |
Current Liabilities | 2,503.48 | 2,202.87 | 2,052.97 | 2,495.71 | 2,491.33 | 2,546.93 | 2,474.66 | 2,167.16 | 2,584.22 | 2,037.81 |
Provisions | 568.07 | 425.02 | 452.51 | 485.05 | 453.7 | 493.21 | 376.65 | 301.8 | 199.66 | 230.81 |
Total Current Liabilities & Provisions | 3,071.55 | 2,627.89 | 2,505.48 | 2,980.76 | 2,945.03 | 3,040.14 | 2,851.31 | 2,468.96 | 2,783.88 | 2,268.62 |
Net Current Assets | 2,398.89 | 2,529.74 | 2,475.53 | 2,401.69 | 2,034.01 | 1,646.05 | 1,918.83 | 1,606.96 | 1,125.56 | 1,485.2 |
Deferred Tax Assets | 2,013 | 1,974.35 | 1,400.02 | 1,383.07 | 1,294.84 | 1,189.75 | 275.92 | 309.88 | 516.75 | 84.14 |
Deferred Tax Liability | 2,113.92 | 1,832.62 | 1,099.93 | 961.41 | 861.63 | 827.4 | 0.04 | 101.41 | 405.31 | 188.84 |
Net Deferred Tax | -100.92 | 141.73 | 300.09 | 421.66 | 433.21 | 362.35 | 275.88 | 208.47 | 111.44 | -104.7 |
Other Assets | 363.55 | 224.91 | 346.4 | 135.39 | 350.33 | 346.61 | 203.18 | 304.72 | 184.91 | 257.2 |
Total Assets | 11,332.98 | 11,982.02 | 10,400.8 | 11,093.89 | 11,064.71 | 11,073.28 | 11,391.87 | 7,131.72 | 6,102.25 | 5,446.34 |
Contingent Liabilities | 157.44 | 150.83 | 128.74 | 122.89 | 129.82 | 125.7 | 122.55 | 109.17 | 95.42 | 33.68 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 169.23 | 169.23 | 84.62 | 84.62 | 84.62 | 84.62 | 84.62 | 84.62 | 84.62 | 84.62 |
Reserves Total | 6,659.53 | 6,286.73 | 6,260.8 | 5,945.48 | 5,036.35 | 4,930.65 | 4,471.87 | 4,369.09 | 3,622.69 | 2,620.97 |
Total Shareholders Funds | 6,828.76 | 6,455.96 | 6,345.42 | 6,030.1 | 5,120.97 | 5,015.27 | 4,556.49 | 4,453.71 | 3,707.31 | 2,705.59 |
Secured Loans | 2,982.96 | 4,365.56 | 3,143.41 | 4,184.78 | 4,991.22 | 5,340.72 | 5,045.27 | 2,431.88 | 2,236.15 | 2,500.05 |
Unsecured Loans | 361.24 | 209.91 | 204.1 | 219.36 | 303.12 | 282.35 | 799.29 | 13.75 | 13.23 | 21.23 |
Total Debt | 3,344.2 | 4,575.47 | 3,347.51 | 4,404.14 | 5,294.34 | 5,623.07 | 5,844.56 | 2,445.63 | 2,249.38 | 2,521.28 |
Other Liabilities | 292.35 | 266.87 | 217.83 | 200.49 | 251.57 | 176.68 | 164.57 | 133.22 | 123.71 | 104.06 |
Total Liabilities | 10,465.31 | 11,298.3 | 9,910.76 | 10,634.73 | 10,666.88 | 10,815.02 | 10,565.62 | 7,032.56 | 6,080.4 | 5,330.93 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 12,999.81 | 12,366.86 | 10,002.35 | 9,952.74 | 9,805.61 | 9,568.39 | 8,905.1 | 4,634.19 | 3,531.56 | 3,416.05 |
Less : Accumulated Depreciation | 5,013.89 | 4,395.01 | 3,751.1 | 3,211.5 | 2,608.11 | 2,143.24 | 1,476.57 | 1,110.7 | 850.17 | 652.55 |
Net Block | 7,985.92 | 7,971.85 | 6,251.25 | 6,741.24 | 7,197.5 | 7,425.15 | 7,428.53 | 3,523.49 | 2,681.39 | 2,763.5 |
Capital Work in Progress | 226.23 | 697.93 | 567.5 | 588.11 | 536.41 | 497.58 | 447.38 | 473.07 | 983.69 | 627.78 |
Investments | 463.31 | 361.21 | 367.64 | 313.92 | 134.89 | 486.22 | 625.05 | 935.84 | 918.15 | 433.83 |
Inventories | 1,565.59 | 1,602.23 | 1,797.11 | 1,911.74 | 1,507.76 | 1,358.3 | 1,299.4 | 1,032.29 | 970.13 | 781.15 |
Sundry Debtors | 1,571.94 | 1,729.44 | 1,541.35 | 1,544.26 | 1,508.94 | 1,356.01 | 1,108.04 | 1,018.47 | 911.5 | 1,181.32 |
Cash and Bank Balance | 108.76 | 147.61 | 69.46 | 66.42 | 390.95 | 237.84 | 57.09 | 78.22 | 82.37 | 69.68 |
Loans and Advances | 353.73 | 291.71 | 468.15 | 480.41 | 411.59 | 445.45 | 699.39 | 629.17 | 409.56 | 403.32 |
Total Current Assets | 3,600.02 | 3,770.99 | 3,876.07 | 4,002.83 | 3,819.24 | 3,397.6 | 3,163.92 | 2,758.15 | 2,373.56 | 2,435.47 |
Current Liabilities | 1,054.53 | 1,021.7 | 927.9 | 1,019.48 | 1,123.82 | 1,120.67 | 1,174.39 | 862.22 | 989.89 | 807.88 |
Provisions | 200.94 | 150.63 | 120.34 | 106.83 | 93.77 | 84.07 | 80.06 | 55.4 | 46.95 | 169.26 |
Total Current Liabilities & Provisions | 1,255.47 | 1,172.33 | 1,048.24 | 1,126.31 | 1,217.59 | 1,204.74 | 1,254.45 | 917.62 | 1,036.84 | 977.14 |
Net Current Assets | 2,344.55 | 2,598.66 | 2,827.83 | 2,876.52 | 2,601.65 | 2,192.86 | 1,909.47 | 1,840.53 | 1,336.72 | 1,458.33 |
Deferred Tax Assets | 405.38 | 612.85 | 796.86 | 1,026.91 | 1,003.33 | 848.97 | 0.82 | 0 | 117.89 | 31.83 |
Deferred Tax Liability | 1,061.19 | 1,014.15 | 990.42 | 998.58 | 935.57 | 856.48 | 0 | 100.73 | 289.19 | 220.67 |
Net Deferred Tax | -655.81 | -401.3 | -193.56 | 28.33 | 67.76 | -7.51 | 0.82 | -100.73 | -171.3 | -188.84 |
Other Assets | 101.11 | 69.95 | 90.1 | 86.61 | 128.67 | 220.72 | 154.37 | 360.36 | 331.75 | 236.33 |
Total Assets | 10,465.31 | 11,298.3 | 9,910.76 | 10,634.73 | 10,666.88 | 10,815.02 | 10,565.62 | 7,032.56 | 6,080.4 | 5,330.93 |
Contingent Liabilities | 1,036.07 | 1,017.36 | 928.05 | 126.18 | 132.56 | 128.58 | 125.48 | 112.09 | 98.41 | 562.25 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 2,352.11 |
Depreciation | 808.27 |
Interest (Net) | 342.08 |
P/L on Sales of Assets | 0.02 |
P/L on Sales of Invest | -17.99 |
Prov. and W/O (Net) | 7.08 |
P/L in Forex | -57.09 |
Total Adjustments (PBT and Ext... | 993.99 |
Operating Profit before Workin... | 3,346.1 |
Trade and 0ther Receivables | 78.32 |
Inventories | -49.43 |
Trade Payables | 413.55 |
Loans and Advances | -6.78 |
Total Adjustments (OP before W... | 418.08 |
Cash Generated from/(used in) ... | 3,764.18 |
Direct Taxes Paid | -498.1 |
Total Adjustments(Cash Generat... | -498.1 |
Cash Flow before Extraordinary... | 3,266.08 |
Net Cash from Operating Activi... | 3,266.08 |
Purchased of Fixed Assets | -432.78 |
Sale of Fixed Assets | 133.66 |
Sale of Investments | 33.09 |
Interest Received | 13.12 |
Net Cash used in Investing Act... | -159.83 |
Of the Long Tem Borrowings | -1,236.01 |
Of the Short Term Borrowings | -133.43 |
Of Financial Liabilities | -23.9 |
Dividend Paid | -1,015.34 |
Interest Paid | -370.96 |
Net Cash used in Financing Act... | -2,779.64 |
Net Profit before Tax and Extr... | 1,916.57 |
Depreciation | 761.05 |
Interest (Net) | 300.5 |
Dividend Received | 50.2 |
P/L on Sales of Assets | -3.03 |
P/L on Sales of Invest | -17.99 |
Prov. and W/O (Net) | 3.92 |
P/L in Forex | -36.64 |
Total Adjustments (PBT and Ext... | 957.61 |
Operating Profit before Workin... | 2,874.18 |
Trade and 0ther Receivables | 139.49 |
Inventories | 36.64 |
Trade Payables | 152.17 |
Loans and Advances | 36.55 |
Total Adjustments (OP before W... | 343.6 |
Cash Generated from/(used in) ... | 3,217.78 |
Direct Taxes Paid | -324.68 |
Total Adjustments(Cash Generat... | -324.68 |
Cash Flow before Extraordinary... | 2,893.1 |
Net Cash from Operating Activi... | 2,893.1 |
Purchased of Fixed Assets | -344.34 |
Sale of Fixed Assets | 31.49 |
Sale of Investments | 33.04 |
Interest Received | 4.18 |
Invest.In Subsidiaires | -128.05 |
Net Cash used in Investing Act... | -296.07 |
Proceed from Short Tem Borrowi... | 2.23 |
Of the Long Tem Borrowings | -1,236.01 |
Of Financial Liabilities | -5.15 |
Dividend Paid | -1,015.34 |
Interest Paid | -323.3 |
Net Cash used in Financing Act... | -2,577.57 |
Company Details
Registered Office |
|
Address | Torrent House, Off Ashram Road |
City | Ahmedabad |
State | Gujarat |
Pin Code | 380009 |
Tel. No. | 91-79-26599000 |
Fax. No. | 91-79-26582100 |
investorservices@torrentpharma.com | |
Internet | http://www.torrentpharma.com |
Registrars |
|
Address | Torrent House |
City | Ahmedabad |
State | Gujarat |
Pin Code | 380009 |
Tel. No. | 91-79-26599000 |
Fax. No. | 91-79-26582100 |
investorservices@torrentpharma.com | |
Internet | http://www.torrentpharma.com |
Management |
|
Name | Designation |
Sudhir Mehta | Chairman Emeritus |
Samir Mehta | Executive Chairman |
Ameera Shah | Independent Director |
Nayantara Bali | Independent Director |
Jinesh Shah | Director (Operation) |
Maurice Chagnaud | Independent Director |
Aman Mehta | Whole Time Director |
Manish Choksi | Independent Director |
Chintan Trivedi | Company Sec. & Compli. Officer |
Nikhil Khattau | Independent Director |
Jindal Mehta | Non Executive Director |